Pharmabiz38m
KL Krems study shows high-volume liposuction significantly increases the likelihood of secondary complications in anaemic lipoedema patients
KL Krems study shows high-volume liposuction significantly increases the likelihood of secondary complications in anaemic lipoedema patients: Krems, Austria Wednesday, February 19 ...
Pharmabiz48m
Jujhar Group with Apollo Hospitals to set up advanced super-speciality unit in Mohali
Jujhar Group with Apollo Hospitals to set up advanced super-speciality unit in Mohali: Our Bureau, Bengaluru Wednesday, February 19, 2025, 14:50 Hrs [IST] Punjab-based Jujhar Grou ...
Pharmabiz58m
Highly complex robotic knee replacement surgery performed at Sohana Multi-Speciality Hospital in Mohali in Punjab
Highly complex robotic knee replacement surgery performed at Sohana Multi-Speciality Hospital in Mohali in Punjab: Our Bureau ...
Pharmabiz1h
LANXESS inaugurates India Application Development Centre
Our Bureau, Mumbai Wednesday, February 19, 2025, 14:30 Hrs [IST] German specialty chemicals company LANXESS today inaugur ...
Pharmabiz1h
Queensland to expand global healthcare frontiers at BioAsia 2025
Queensland to expand global healthcare frontiers at BioAsia 2025: Our Bureau, Bengaluru Wednesday, February 19, 2025, 14:15 Hrs [IST] Trade and Investment Queensland (TIQ), the de ...
Pharmabiz1h
Eisai announces Leqembi sales reaches €200 million; BioArctic to receive €10 million payment
Eisai announces Leqembi sales reaches €200 million; BioArctic to receive €10 million payment: Stockholm, Sweden Wednesday, February 19, 2025, 14:00 Hrs [IST] BioArctic AB’s ...
Pharmabiz1h
Roche Diagnostics India screens 5,000 children for eye health across Palghar, Nanded, Mumbai and Delhi
Roche Diagnostics India and neighbouring markets under the aegis of its flagship CSR initiative Project Roshni conducted eye check-up camps to screen 5,000 children across Palghar, Nanded, Mumbai and ...
Pharmabiz2h
AlgoTherapeutix announces results of its phase 2 “ACT” trial of ATX01 in chemotherapy-induced peripheral neuropathy
AlgoTherapeutix announces results of its phase 2 “ACT” trial of ATX01 in chemotherapy-induced peripheral neuropathy: Paris, France Wednesday, February 19, 2025, 13:00 Hrs [IST ...
Pharmabiz3h
US FDA accepts for priority review Sanofi & Regeneron’s Dupixent sBLA for the targeted treatment of bullous pemphigoid
US FDA accepts for priority review Sanofi & Regeneron’s Dupixent sBLA for the targeted treatment of bullous pemphigoid: Paris Wednesday, February 19, 2025, 12:00 Hrs [IST] The U ...
Pharmabiz4h
New research highlights the role of aspirin and advanced ultrasound techniques in cardiovascular health
New research highlights the role of aspirin and advanced ultrasound techniques in cardiovascular health: Basel, Switzerland Wednesday, February 19, 2025, 11:00 Hrs [IST] With the ...
Pharmabiz5h
Merck’s Welireg receives European approval for two indications
Merck’s Welireg receives European approval for two indications: Rahway, New Jersey Wednesday, February 19, 2025, 10:00 Hrs [IST] Merck, known as MSD outside of the United States ...
Pharmabiz6h
Apollo Hospitals to host International Health Dialogue 2025 in New Delhi
Apollo Hospitals to host International Health Dialogue 2025 in New Delhi: Our Bureau, Chennai Wednesday, February 19, 2025, 09:00 Hrs [IST] Apollo Hospitals will host the Internat ...